Insider: Fitzgerald Kevin Joseph CSO & EVP, Head of Research - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 23,947 | 0 | 23,947 |
| Value | $10,689,940.80 | $0.00 | $10,689,940.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/18/2025 | DDS | 39 | Direct | COM | $450.92 | $17,585.88 | 23,947 |
| 08/18/2025 | DDS | 90 | Direct | COM | $449.92 | $40,492.80 | 23,986 |
| 08/18/2025 | DDS | 12 | Direct | COM | $455.82 | $5,469.84 | 22,719 |
| 08/18/2025 | DDS | 103 | Direct | COM | $451.99 | $46,554.97 | 23,844 |
| 08/18/2025 | DDS | 39 | Direct | COM | $447.98 | $17,471.22 | 24,076 |
| 08/18/2025 | DDS | 241 | Direct | COM | $454.84 | $109,616.44 | 22,731 |
| 08/18/2025 | DDS | 543 | Direct | COM | $454.04 | $246,543.72 | 22,972 |
| 08/18/2025 | DDS | 329 | Direct | COM | $452.96 | $149,023.84 | 23,515 |
| 03/04/2025 | DDS | 121 | Direct | COM | $239.24 | $28,948.04 | 14,224 |
| 03/04/2025 | DDS | 328 | Direct | COM | $240.95 | $79,031.60 | 13,896 |
| 03/04/2025 | DDS | 324 | Direct | COM | $241.68 | $78,304.32 | 13,572 |
| 03/04/2025 | DDS | 71 | Direct | COM | $242.93 | $17,248.03 | 13,501 |
| 03/03/2025 | DDS | 111 | Direct | COM | $245.26 | $27,223.86 | 15,566 |
| 03/03/2025 | DDS | 151 | Direct | COM | $244.41 | $36,905.91 | 15,677 |
| 03/03/2025 | DDS | 45 | Direct | COM | $246.18 | $11,078.10 | 15,521 |
| 03/03/2025 | DDS | 204 | Direct | COM | $242.37 | $49,443.48 | 16,052 |
| 03/03/2025 | DDS | 224 | Direct | COM | $243.36 | $54,512.64 | 15,828 |
| 03/03/2025 | DDS | 4 | Direct | COM | $247.35 | $989.40 | 15,517 |
| 03/03/2025 | DDS | 487 | Direct | COM | $243.94 | $118,798.78 | 14,564 |
| 03/03/2025 | DDS | 219 | Direct | COM | $245.30 | $53,720.70 | 14,345 |
| 03/03/2025 | DDS | 1 | Direct | COM | $248.36 | $248.36 | 15,516 |
| 03/03/2025 | DDS | 465 | Direct | COM | $242.69 | $112,850.85 | 15,051 |
| 02/28/2025 | DDS | 22 | Direct | COM | $239.18 | $5,261.96 | 12,811 |
| 02/28/2025 | DDS | 27 | Direct | COM | $236.51 | $6,385.77 | 12,854 |
| 02/28/2025 | DDS | 48 | Direct | COM | $240.32 | $11,535.36 | 12,763 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research